Risk of Post-SSRI Sexual Dysfunction: A Retrospective Study
A recent retrospective cohort study has shed light on the small but significant risk of Post-SSRI Sexual Dysfunction (PSSD) in males treated with serotonergic antidepressants (SAs). Conducted over 19 years, the study involved 12,302 males and aimed to assess the likelihood of developing erectile dysfunction (ED) and PSSD following SA treatment.
The results show that males treated with SAs have a more than threefold increased risk of ED, with 0.46% developing PSSD. This finding highlights the need for open communication about the potential long-term sexual side effects of antidepressants.
While PSSD is rare, its implications are serious, making it crucial for healthcare providers to discuss these risks with patients before prescribing serotonergic antidepressants.
Read the full study here.
Learn more about PFS & PSSD
What is Post-Finasteride Syndrome?
Learn more about the devastating disease known as Post-Finasteride Syndrome.
What is Post-SSRI Sexual Dysfunction?
Gain insight on PSSD – Post-SSRI Sexual Dysfunction and it’s life-altering side effects.